APA aipamena

Gu, L., Liao, Z., Hoang, D., Dagvadorj, A., Gupta, S., Blackmon, S., . . . Nevalainen, M. T. (2013). PHARMACOLOGICAL INHIBITION OF JAK2-STAT5 SIGNALING BY JAK2 INHIBITOR AZD1480 POTENTLY SUPPRESSES GROWTH OF BOTH PRIMARY AND CASTRATE-RESISTANT PROSTATE CANCER. Clin Cancer Res.

Chicago Style aipamena

Gu, Lei, et al. "PHARMACOLOGICAL INHIBITION OF JAK2-STAT5 SIGNALING BY JAK2 INHIBITOR AZD1480 POTENTLY SUPPRESSES GROWTH OF BOTH PRIMARY AND CASTRATE-RESISTANT PROSTATE CANCER." Clin Cancer Res 2013.

MLA aipamena

Gu, Lei, et al. "PHARMACOLOGICAL INHIBITION OF JAK2-STAT5 SIGNALING BY JAK2 INHIBITOR AZD1480 POTENTLY SUPPRESSES GROWTH OF BOTH PRIMARY AND CASTRATE-RESISTANT PROSTATE CANCER." Clin Cancer Res 2013.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.